431052-32-3

Upstream product

• 22921-68-2 2-bromo-5-methoxy-benzoic acid 
• 35450-36-3 methyl 2-bromo-5-methoxybenzoate 
• 100-39-0 benzyl bromide 
• 154607-00-8 methyl 3-hydroxy-6-bromobenzoate 

Downstream Products

• 1319804-25-5 5-benzyloxy-3,3-dideuterio-1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborole 
• 1392119-23-1 5-benzyloxy-2-(3-hydroxyprop-1-ynyl)benzoic acid methyl ester 
• 1392119-24-2 5-benzyloxy-2-[3-(tert-butyldimethylsilanyloxy)prop-1-ynyl]benzoic acid methyl ester 
• 1392119-25-3 7-benzyloxy-4-bromo-3-(tert-butyldimethylsilanyloxymethyl)isochromen-1-one 
• 1392119-26-4 7-benzyloxy-3-(tert-butyldimethylsilanyloxymethyl)-4-(5-methylchroman-6-yl)isochromen-1-one 
• 1392119-28-6 7-benzyloxy-3-hydroxymethyl-2-methyl-4-(5-methylchroman-6-yl)-2H-isoquinolin-1-one 
• 1392119-30-0 7-benzyloxy-2-methyl-4-(5-methylchroman-6-yl)-1-oxo-1,2-dihydroisoquinoline-3-carbaldehyde 
• 1392119-32-2 [7-benzyloxy-2-methyl-4-(5-methylchroman-6-yl)-1-oxo-1,2-dihydroisoquinolin-3-yl]trimethylsilanyloxyacetonitrile 

Relevant academic research and scientific papers

7- OR 8-HYDROXY-ISOQUINOLINE AND 7- OR 8-HYDROXY-QUINOLINE DERIVATIVES AS ALPHA-1 -ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1 -ANTITRYPSIN DEFICIENCY (AATD)

7- or 8-hydroxy-isoquinoline and 7- or 8-hydroxy-quinoline derivatives as alpha-l-antitrypsin modulators for treating alpha-l-antitrypsin deficiency (AATD).

ISOQUINOLINE COMPOUNDS AND METHODS FOR TREATING HIV

Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the retrovirus family of viruses such as the Human Immunodeficiency Virus (HIV).

BORON-CONTAINING SMALL MOLECULES

Compounds, pharmaceutical formulations, and methods of treating anti-inflammatory conditions and/or helminth-associated diseases are disclosed.